Aclaris therapeutics to announce first quarter 2023 financial results on may 8, 2023

Wayne, pa., may 02, 2023 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced it will report financial results for the first quarter 2023 on monday, may 8, 2023, before the opening of the u.s. financial markets.
ACRS Ratings Summary
ACRS Quant Ranking